Publikationen, an denen er mitarbeitet Lidia Ruiz Llorente (3)

2022

  1. Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn’s Disease Severity

    Biomedicines, Vol. 10, Núm. 3

  2. Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies

    Current Oncology, Vol. 29, Núm. 4, pp. 2442-2453

2021

  1. Towards an updated view on the clinical management of pancreatic adenocarcinoma: Current and future perspectives (Review)

    Oncology Letters, Vol. 22, Núm. 5